[Cerebral toxoplasmosis in patients with acquired immunodeficiency syndrome: does the early administration of treatment contribute to improve survival?].
Miralles
R
R
Gallén
M
M
Garcés
J M
JM
López-Colomés
J L
JL
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality*; D001927:Brain Diseases / Q000188:drug therapy*; D015996:Survival Rate; D013997:Time Factors; D014123:Toxoplasmosis / Q000188:drug therapy*
Toxoplasmosis cerebral en pacientes con síndrome de inmunodeficiencia adquirida: contribuye a mejorar la supervivencia la instauración de un tratamiento temprano?